Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: A randomized placebo-controlled study in the United States

William J. Tremaine*, Stephen B. Hanauer, Seymour Katz, Barry D. Winston, Jeffrey G. Levine, Tore Persson, Anders Persson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint Dive into the research topics of 'Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: A randomized placebo-controlled study in the United States'. Together they form a unique fingerprint.

Medicine & Life Sciences